Brookline Ziopharm Investment Fund II, LLC — Form D
Brookline Ziopharm Investment Fund II, LLC of BIRMINGHAM, AL, a company, filed a Form D exempt-offering notice with the SEC on 2009-12-10. The offering totals $5.0M, of which $1.0M was reported sold. Industry: Investing.
Offering
- Filed: 2009-12-10
- Form: D
- Accession: 0001478316-09-000001
- Industry: Investing
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $1.0M
- Remaining: $4.0M
- Minimum investment: $25K
- Date of first sale: 2009-12-04
- Revenue range: $1 - $1,000,000
- SEC file number: 021-136794
Issuer
- Name: Brookline Ziopharm Investment Fund II, LLC
- CIK: 0001478316
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 2501 20TH PLACE SOUTH, SUITE 275, BIRMINGHAM, AL, 35223
- Phone: 205-263-2332
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| James E Cantrell, Jr., M.D. | Executive Officer | Birmingham, AL |
| Jimmie Huling Harvey, Jr., M.D. | Executive Officer | Birmingham, AL |
| Madding King, III | Executive Officer | Birmingham, AL |
| J. Rainer Twiford | Executive Officer | Birmingham, AL |
More